HomeSNDX • NASDAQ
add
Syndax Pharmaceuticals Inc
Previous close
$16.37
Day range
$15.53 - $16.50
Year range
$8.58 - $22.50
Market cap
1.34B USD
Avg Volume
2.62M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 37.96M | 984.51% |
Operating expense | 43.80M | 50.73% |
Net income | -71.85M | -5.56% |
Net profit margin | -189.28 | 90.27% |
Earnings per share | -0.83 | -3.75% |
EBITDA | -69.35M | 6.55% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 468.71M | 8.43% |
Total assets | 596.15M | 24.99% |
Total liabilities | 438.72M | 929.65% |
Total equity | 157.42M | — |
Shares outstanding | 86.14M | — |
Price to book | 8.95 | — |
Return on assets | -28.04% | — |
Return on capital | -32.60% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -71.85M | -5.56% |
Cash from operations | -87.80M | -22.54% |
Cash from investing | 41.89M | -32.17% |
Cash from financing | 551.00K | -18.49% |
Net change in cash | -45.36M | -391.99% |
Free cash flow | -51.76M | -8.21% |
About
Founded
2005
Website
Employees
270
